Skip to main content
Peter Siekmeier, MD, Psychiatry, Belmont, MA

PeterJSiekmeierMDMS

Psychiatry Belmont, MA

Director, Laboratory for Computational Neuroscience, McLean Hospital; Attending Psychiatrist, McLean Hospital

Dr. Siekmeier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Siekmeier's full profile

Already have an account?

  • Office

    115 Mill St
    Belmont, MA 02478
    Phone+1 617-855-3588
    Fax+1 617-855-3789

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1997 - 2001
  • Yale School of Medicine
    Yale School of MedicineClass of 1997
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyMS, 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1999 - 2026
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Travel Award American College of Neuropsychopharmacology, 2012

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased beta-gamma power ratio in MEG auditory steady-state responses: A potential biomarker for chronic schizophrenia
    Siekmeier, P.J., Stufflebeam, S.M., Spencer, S.K., Hamalainen, M., McCarley, R., Neuropsychopharmacology, 12/10/2014
  • Treatment of dopaminergic dysfunction in schizophrenia using non-dopaminergic mechanisms: A computational modeling approach
    Siekmeier, P.J. and vanMaanen, D.P., Neuropsychopharmacology, 12/9/2013
  • Novel EEG biomarkers for the a priori identification of responders to the experimental antipsychotic agen pomaglumetad methionil
    Siekmeier, P.J. and Lowen, S.B., Neuropsychopharmacology, Florida, 12/11/2019
  • Join now to see all

Other

Press Mentions

  • Farewell
    FarewellMay 8th, 2017
  • Recent patent applications in drug screening
    Recent patent applications in drug screeningSeptember 28th, 2021
  • Long-time interest in biorhythms settles into fascination with oscillations in cognition
    Long-time interest in biorhythms settles into fascination with oscillations in cognitionOctober 21st, 2021

Grant Support

  • Computational Modeling Of Hippocampus In SchizophreniaNational Institute Of Mental Health2007–2011
  • The Use of a Neurocomputational Model to Examine the Hippocampal Etiologies of Schizophrenia and Develop More Effective Pharmacologic TreatmentsNational Alliance for Research on Schizophrenia and Depression (NARSAD)2004–2006
  • Use of a Computational Model of Hippocampus Subfield CA1 to Examine the Neuropathology of SchizophreniaNational Alliance for Research on Schizophrenia and Depression (NARSAD)2002–2004

Professional Memberships